These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22155131)

  • 21. Antimicrobial potential of a lipopeptide biosurfactant derived from a marine Bacillus circulans.
    Das P; Mukherjee S; Sen R
    J Appl Microbiol; 2008 Jun; 104(6):1675-84. PubMed ID: 18194244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents.
    Conlon JM; Al-Ghaferi N; Abraham B; Leprince J
    Methods; 2007 Aug; 42(4):349-57. PubMed ID: 17560323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antimicrobial activity of essential oil from Dracocephalum foetidum against pathogenic microorganisms.
    Lee SB; Cha KH; Kim SN; Altantsetseg S; Shatar S; Sarangerel O; Nho CW
    J Microbiol; 2007 Feb; 45(1):53-7. PubMed ID: 17342056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approaches in the safety evaluations of veterinary antimicrobial agents in food to determine the effects on the human intestinal microflora.
    Cerniglia CE; Kotarski S
    J Vet Pharmacol Ther; 2005 Feb; 28(1):3-20. PubMed ID: 15720510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond the target pathogen: ecological effects of the hospital formulary.
    Goldstein EJ
    Curr Opin Infect Dis; 2011 Feb; 24 Suppl 1():S21-31. PubMed ID: 21200181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial peptides: review of their application in musculoskeletal infections.
    Stallmann HP; Faber C; Nieuw Amerongen AV; Wuisman PI
    Injury; 2006 May; 37 Suppl 2():S34-40. PubMed ID: 16651070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colonization of the oropharynx with pathogenic microorganisms--a potential risk factor for infection in compromised patients.
    Heimdahl A; Nord CE
    Chemioterapia; 1985 Apr; 4(2):186-91. PubMed ID: 4006007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind, placebo-controlled study comparing the effect of azithromycin with clarithromycin on oropharyngeal and bowel microflora in volunteers.
    Matute AJ; Schurink CA; Krijnen RM; Florijn A; Rozenberg-Arska M; Hoepelman IM
    Eur J Clin Microbiol Infect Dis; 2002 Jun; 21(6):427-31. PubMed ID: 12111597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human health hazard from antimicrobial-resistant enterococci in animals and food.
    Heuer OE; Hammerum AM; Collignon P; Wegener HC
    Clin Infect Dis; 2006 Oct; 43(7):911-6. PubMed ID: 16941376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Manipulation of the oropharyngeal and intestinal microflora by norfloxacin: microbiological and clinical aspects.
    Edlund C; Nord CE
    Scand J Infect Dis Suppl; 1988; 56():14-21. PubMed ID: 3074461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flavophospholipol use in animals: positive implications for antimicrobial resistance based on its microbiologic properties.
    Pfaller MA
    Diagn Microbiol Infect Dis; 2006 Oct; 56(2):115-21. PubMed ID: 16698216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections.
    Nord CE; Kager L; Heimdahl A
    Am J Med; 1984 May; 76(5A):99-106. PubMed ID: 6372482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of new antimicrobial agents against glycopeptide-resistant Enterococcus faecium clinical isolates from France between 2006 and 2008.
    Bérenger R; Bourdon N; Auzou M; Leclercq R; Cattoir V
    Med Mal Infect; 2011 Aug; 41(8):405-9. PubMed ID: 21550192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Globalization of antimicrobial resistance: epidemiological challenges.
    Williams RJ
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S116-7. PubMed ID: 11524706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria.
    Raad I; Reitzel R; Jiang Y; Chemaly RF; Dvorak T; Hachem R
    J Antimicrob Chemother; 2008 Oct; 62(4):746-50. PubMed ID: 18653489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial agents as biological response modifiers (BRM) and chrono-immunomodulation: an emerging relationship.
    Dammacco F; Halberg F; Carandente F
    Chronobiologia; 1988; 15(1-2):25-39. PubMed ID: 3046851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of the antimicrobial agent susceptibility study raised in a representative, cross-sectional monitoring study on a national basis.
    Kaspar H
    Int J Med Microbiol; 2006 Jun; 296 Suppl 41():69-79. PubMed ID: 16531116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial and antibiofilm activity of pleurocidin against cariogenic microorganisms.
    Tao R; Tong Z; Lin Y; Xue Y; Wang W; Kuang R; Wang P; Tian Y; Ni L
    Peptides; 2011 Aug; 32(8):1748-54. PubMed ID: 21703317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral streptococci exhibit diverse susceptibility to human beta-defensin-2: antimicrobial effects of hBD-2 on oral streptococci.
    Nishimura E; Eto A; Kato M; Hashizume S; Imai S; Nisizawa T; Hanada N
    Curr Microbiol; 2004 Feb; 48(2):85-7. PubMed ID: 15057473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial activity of synthetic salivary peptides against voice prosthetic microorganisms.
    Elving GJ; van der Mei HC; Busscher HJ; van Nieuw Amerongen A; Veerman EC; van Weissenbruch R; Albers FW
    Laryngoscope; 2000 Feb; 110(2 Pt 1):321-4. PubMed ID: 10680938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.